ASURAGEN, INC.
AUSTIN, TX

Asuragen, Inc. is a global molecular diagnostics company based in Austin, Texas, founded by Dr. Matt Winkler in 2005 with the vision to leverage novel molecular technology for cutting-edge diagnostics. The company has built its reputation on translating scientific excellence into solutions aimed at addressing unmet needs in molecular oncology and genetics, developing diagnostic products and services that deliver actionable insights for patients worldwide. Asuragen holds a diverse team of professionals ranging from experienced industry executives to top-notch scientists and respected researchers within an emerging rapid-growth environment. The company encourages innovation through its culture, allowing employees the freedom to be creative while fostering collaborative efforts in solving customer needs and achieving company objectives. With strategic leadership from figures like Bernard Andruss as President and Shane V Bohnen as VP, Asuragen continues to expand its capabilities in molecular diagnostics. With a commitment to precision medicine and patient-managed healthcare transformation, the company prioritizes hiring motivated scientists interested in advancing genomic medicine through collaborative projects that lead to significant scientific publications and intellectual property growth. Asuragen's history of impactful partnerships includes collaborations with leading clinicians and researchers, and having raised over $25M in sponsored research funding during Bernard Andruss’s tenure post spinoff from Ambion. Incorporated as a Florida entity (Filenum: F11000003881), the company is registered to operate out of 2150 Woodward St., Suite 100, Austin, TX and maintains its corporate headquarters at the same location. Asuragen can be contacted through multiple lines including its primary phone numbers (877) 777-1874 and (512) 681-5201 alongside an extensive network in various regions. The latest annual report was filed on January 7, 2025, and it operates under a For-Profit (FORP) business model with a tax identification number of 20-4167524. For more detailed information or career opportunities at Asuragen, Inc., please visit their website at www.asuragen.com.

KEY FACTS ABOUT ASURAGEN, INC.

Company name
ASURAGEN, INC.
Status
Active
Filed Number
F11000003881
FEI Number
20-4167524
Date of Incorporation
September 27, 2011
Age - 14 years
Home State
DE
Company Type
Foreign for Profit

CONTACTS

Website
http://asuragen.com
Phones
(877) 777-1874
(512) 681-5201
(512) 681-5200
(511) 566-0400
(511) 566-2886
(191) 495-8210
(191) 487-4285
(877) 772-8018
(512) 681-5205

ASURAGEN, INC. NEAR ME

Principal Address
2150 WOODWARD ST, SUITE 100,
AUSTIN,
TX,
78744,
US

See Also

Officers and Directors

The ASURAGEN, INC. managed by the three persons from Minneapolis, AUSTIN on following positions: VP,, President, Director

Shane V Bohnen

Position
VP, Active
From
Minneapolis, MN, MN

Bernard Andruss

Position
President Active
From
AUSTIN, TX, TX

Kim Kelderman

Position
Director Active
From
Minneapolis, MN, MN





Registered Agent is CORPORATION SERVICE COMPANY

Address
1201 HAYS STREET, TALLAHASSEE, FL, 32301, 2525

Annual Reports

2025
January 7, 2025
2024
March 8, 2024